Predictive Oncology Inc.

NASDAQ
POAI
paper.types.company
Rentabilité sur six mois: +16.4%
Rendement en dividendes: 0%
Secteur: Healthcare

0.905 $

0 $ 0%
0.5501 $
1.95 $

paper.min_max_per_year

Calendrier des promotions Predictive Oncology Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Predictive Oncology Inc.

Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline.

plus de détails
The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Paramètres de base

IPO date
2018-01-29
ISIN
US74039M2008
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
lien
Tous les paramètres

Grade

Sous-estimation
Nom Signification Grade
P/S 2.75 6
P/BV -22.07 0
P/E 0 0
Efficacité
Nom Signification Grade
ROA -125.85 0
ROE -302.42 0
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA -0.2096 10
Debt/Ratio 0.4286 10
Debt/Equity -25.54 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 24.91 4
Rentabilité Ebitda, % -2931.35 0
Rentabilité EPS, % -97.38 0
Plus de détails

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 0.905 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 1.09 $ 0 $ 0 $ -16.97 % 0 % 0 %
common.calendar.number_days.30d 1.06 $ 0.905 $ 1.1 $ -14.62 % 0 % 0 %
common.calendar.number_days.90d 1.42 $ 0.868 $ 1.69 $ -36.27 % 0 % 0 %
common.calendar.number_days.180d 0.7775 $ 0.686 $ 1.95 $ 16.4 % 0 % 0 %
common.calendar.number_days.1y 1.93 $ 0.5501 $ 1.95 $ -53.11 % 0 % 0 %
common.calendar.number_days.3y 0.362 $ 0.334 $ 12.15 $ 150 % 0 % 0 %
common.calendar.number_days.5y 1.44 $ 0.27 $ 12.15 $ -37.15 % 0 % 0 %
common.calendar.number_days.10y 0 $ 0.08 $ 12.15 $ 0 % 0 % 0 %
common.calendar.number_days.ytd 0.73 $ 0.868 $ 1.95 $ 23.97 % 0 % 0 %

Principaux propriétaires

Entreprises similaires

P/E & P/BVEV/Ebitda & Debt/Ebitda


Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Joshua Blacher M.B.A. Interim Chief Financial Officer N/A 1973 (52 année)
Ms. Theresa Ferguson Senior Director of Marketing N/A
Dr. Lawrence J. DeLucas D.Sc, O.D, Ph.D. Senior Vice President of Biologics N/A
Dr. Arlette H. Uihlein FCAP, M.D. Senior VP of Translational Medicine & Drug Discovery and Medical Director N/A
Mr. Raymond F. Vennare CEO & Chairman 581.58k 1953 (72 année)

Informations sur l'entreprise

Adresse: United States, Eagan. MN, 2915 Commers Drive - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.predictive-oncology.com